Company intelligence / Profile preview
Guangzhou Baiyunshan Zhongyi Pharmaceutical
Guangzhou, Guangdong, Chinabyszc.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Guangzhou Baiyunshan Zhongyi Pharmaceutical is a leading Chinese pharmaceutical manufacturer specializing in traditional Chinese medicines with a growing portfolio of chemical drugs. Its flagship TCMs are approved and widely used across China. The company has also developed generic small molecules including antibiotics that have reached commercial stage. Select innovative programs are advancing through clinical trials—most notably an oncology asset targeting RET currently at Phase 2.
- Therapeutic areas
- NeurologyPulmonologyInfectious DiseasesEndocrinologyOncologyWomen's Health
- Modalities
- Herbal medicineSmall moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
Beyond the preview
Go deeper on Guangzhou Baiyunshan Zhongyi Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou Baiyunshan Zhongyi Pharmaceutical.